Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Rackspace Technology Inc. Common Stock (RXT) vs Tango Therapeutics Inc. (TNGX) Price & Performance

Rackspace Technology Inc. Common StockTrade
Tango Therapeutics Inc.Trade

Price performance (Past 24H)

Key statistics

Rackspace Technology Inc. Common Stock vs Tango Therapeutics Inc. — how do they compare? Rackspace Technology Inc. Common Stock trades at $3.08 (market cap $925.19M), while Tango Therapeutics Inc. trades at $22.23 (market cap $3.75B). The key difference: Tango Therapeutics Inc. is far larger — about 4.1× Rackspace Technology Inc. Common Stock's market cap, and Tango Therapeutics Inc. is trading nearer its 52-week high, Rackspace Technology Inc. Common Stock nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Rackspace Technology Inc. Common Stock for 0 Days and Tango Therapeutics Inc. for 0 Days on average.

RXTTNGX
Market Cap
$925.19M$3.75B
Volume
2,631,3649,619,106
Sector
TechnologyHealth
52-Week High
$7.53$32.90
52-Week Low
$0.41$7.50
Typical Hold Time
0 Days0 Days
Enterprise Value
$4.09B$2.77B

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Rackspace Technology Inc. Common Stock

No Aura AI signal available yet.

Tango Therapeutics Inc.

TNGX trades at $22.22, down 8.07% in the last session, reflecting negative investor reaction to recent earnings misses. The stock shows neutral technical signals with key support at $21 and resistance at $23. Fundamentally, the company maintains a high gross margin of 98.25% but faces significant losses with a net income margin of -229.92% and negative cash flow from operations. Recent news highlights institutional buying interest and upcoming clinical trial developments.

Despite strong analyst support with a $45.91 consensus price target (107% upside), TNGX faces substantial execution risks as a clinical-stage biotech. The company's heavy cash burn and lack of profitability require careful monitoring of pipeline progress. Investment appeal hinges on successful drug development outcomes rather than current financial metrics.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

RXT
100% Buy0% Sell
Avg holding period · 0 Days
TNGX
100% Buy0% Sell
Avg holding period · 0 Days

About Rackspace Technology Inc. Common Stock

Rackspace Technology, Inc. provides managed multicloud and hybrid cloud services, helping organizations design, operate, and support workloads across AWS, Microsoft Azure, Google Cloud, and private infrastructure.

Read more on RXT →

About Tango Therapeutics Inc.

Tango Therapeutics, Inc. is a clinical-stage biotechnology company focused on precision oncology, developing cancer therapies based on the genetic principle of synthetic lethality, including its PRMT5 inhibitor program.

Read more on TNGX →